InvestorsHub Logo
Followers 23
Posts 1725
Boards Moderated 0
Alias Born 09/03/2015

Re: namtae post# 13296

Saturday, 11/11/2017 1:51:35 PM

Saturday, November 11, 2017 1:51:35 PM

Post# of 21373
Yes business is slow, welcome to the world of a clinical stage biopharma that has already burned through $15m-$20m in VC money.

Could they have tried to go through more rounds of VC funding and the whole process of presenting to investors in the hopes of getting more investors on board? Yes they could. But that is a long drawn out process. They are in the midst of phase I trials and need capital now. The decision was made to go public and secure an equity investment in the fastest manner possible to get the "slow business" back on track.

They don't have time to waste as they need capital to manufacture more Prolanta to complete these trials asap.

I know you must have been a great CEO for a pharmaceutical company at some point, because you seem to have all the answers. Have you thought about contacting Michael Redman to see if he would bring you on board as an advisor/consultant? Because his 30+ years of experience in the industry doesn't seem to be doing him any good by your standards.

Oncolix could really use your expertise as a serious asset. I'm being dead serious too.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.